Englander Institute for Precision Medicine
Photo: Shutterstock

EIPM's Clinical Director Cora Sternberg, M.D. on PROSPER Trial

May 29, 2020

A drug that blocks a male hormone receptor prolonged life by nearly a year compared with the placebo in men with nonmetastatic, castration-resistant prostate cancer, according to the final analysis of the results of an international, multi-center Phase 3 clinical trial led by Weill Cornell Medicine and NewYork-Presbyterian investigators. Both groups of men were additionally treated with a...

Read More
Photo: EIPM

A Conversation with Princesca Dorsaint

May 7, 2020

Princesca Dorsaint is a Bioinformatics Analyst at the Englander Institute for Precision Medicine. She was born and raised in New York, and received her undergraduate degree in Health Science from The University of Hartford, and then later pursued a second undergraduate degree in Biomedical Informatics from The New York City College of Technology. She has been at Weill Cornell Medicine for a year and a half.

We hope you enjoy learning more about Princesca, her career goals, and how she’...

Read More
Photo: WCM

Treating Cancer Patients Amid the Pandemic

April 24, 2020

A diagnosis of cancer is one of the most frightening things a patient could ever receive . Despite great advances made in treatment, early detection, and prevention, patients will often feel vulnerable and lost in a maze of the unknown. And now, in the face of the ongoing coronavirus pandemic, every one of us — the healthy and those with health ailments — also feels vulnerable.

...
Read More